-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FIJrteAlk6pgYsIXdvVyMxnCffoYnG8A0xwEJUnRYwnVJ8vUwCSHkPf5xCpbRuRY tU62BuzAouXATlrzeKpAuA== 0001144204-10-012508.txt : 20100310 0001144204-10-012508.hdr.sgml : 20100310 20100310160733 ACCESSION NUMBER: 0001144204-10-012508 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100308 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCGEE BRIAN CENTRAL INDEX KEY: 0001284144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 10670622 MAIL ADDRESS: STREET 1: 201 BRIDGELAND AVE STREET 2: TORONTO CITY: ONTARIO CANDA M6A 1Y7 STATE: A6 ZIP: 00000 4 1 v176794_ex.xml X0303 4 2010-03-08 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001284144 MCGEE BRIAN C/O GENEREX BIOTECHNOLOGY CORPORATION 33 HARBOUR SQUARE, SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 1 0 0 0 Common Stock Purchase Option (right to buy) .94 2009-10-20 4 D 0 70000 0 D 2009-10-26 Common Stock 70000 0 D Common Stock Purchase Option (right to buy) .94 2009-10-20 4 A 0 70000 0 A 2014-10-26 Common Stock 70000 70000 D Common Stock Purchase Option (right to buy) .001 2009-10-20 4 D 0 35714 0 D 2010-04-04 Common Stock 35714 0 D Common Stock Purchase Option (right to buy) .001 2009-10-20 4 A 0 35714 0 A 2014-10-26 Common Stock 35714 35714 D Common Stock Purchase Option (right to buy) .56 2009-10-20 4 D 0 100000 0 D 2010-04-04 Common Stock 100000 0 D Common Stock Purchase Option (right to buy) .56 2009-10-20 4 A 0 100000 0 A 2014-10-26 Common Stock 100000 100000 D Common Stock Purchase Option (right to buy) .64 2010-03-08 4 A 0 100000 0 A 2020-03-07 Common Stock 100000 100000 D Deemed cancellation of option in connection with deemed grant of replacement option. The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on October 26, 2004. The original terms of vesting were not amended. The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended. The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended. This option becomes exercisable in three installments, with the first installment (33,333 shares) exercisable as of the date of grant, the second installment (33,3333 shares) exercisable as of August 1, 2010 and the third installment (33,334 shares) exercisable as of August 1, 2011. /s/ Brian McGee 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----